Kane Biotech Inc. (KNBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0290
-0.0035 (-10.77%)
Feb 12, 2026, 11:21 AM EST

Kane Biotech Revenue

Kane Biotech had revenue of 8.50K CAD in the quarter ending September 30, 2025, a decrease of -99.34%. This brings the company's revenue in the last twelve months to 574.87K, down -71.44% year-over-year. In the year 2024, Kane Biotech had annual revenue of 2.08M with 1,296.75% growth.

Revenue (ttm)
574.87K CAD
Revenue Growth
-71.44%
P/S Ratio
12.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.35M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.08M1.93M1,296.75%
Dec 31, 2023148.98K-7.75K-4.95%
Dec 31, 2022156.73K-1.45M-90.25%
Dec 31, 20211.61M266.20K19.84%
Dec 31, 20201.34M-351.95K-20.78%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LakeShore Biopharma84.75M
Vaccinex601.00K
GPL Holdings376.54K
AXIM Biotechnologies92.90K
Enzon Pharmaceuticals26.00K
Revenue Rankings